Rapid Dose Therapeutics Corp. DOSE
CNSX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.13% | 28.03% | 37.64% | -35.74% | -16.92% |
| Total Depreciation and Amortization | -3.20% | 2.10% | -5.40% | -8.01% | 3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.27% | 328.57% | -92.97% | 138.09% | -16.27% |
| Change in Net Operating Assets | 103.78% | -80.45% | 2,092.82% | -20.34% | 133.52% |
| Cash from Operations | -123.05% | -92.64% | 328.10% | 22.63% | 20.53% |
| Capital Expenditure | -- | -- | -- | -- | -16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -16.67% |
| Total Debt Issued | 313.33% | 100.60% | -787.66% | 62.80% | 97.77% |
| Total Debt Repaid | -3.04% | 85.54% | -576.92% | -25.16% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -73.52% |
| Cash from Financing | 110.37% | 98.73% | -1,186.52% | 8.06% | -42.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -286.96% | 103.24% | -198.47% | 254.72% | -226.63% |